FY2024 Earnings Forecast for Jushi Issued By Atb Cap Markets

Jushi Holdings Inc. (OTCMKTS:JUSHF) – Research analysts at Atb Cap Markets decreased their FY2024 EPS estimates for shares of Jushi in a research note issued on Sunday, November 10th. Atb Cap Markets analyst F. Gomes now anticipates that the company will post earnings per share of ($0.24) for the year, down from their prior estimate of ($0.20). The consensus estimate for Jushi’s current full-year earnings is ($0.19) per share. Atb Cap Markets also issued estimates for Jushi’s Q4 2024 earnings at ($0.06) EPS, FY2025 earnings at ($0.19) EPS, FY2026 earnings at ($0.15) EPS, FY2027 earnings at ($0.12) EPS and FY2028 earnings at ($0.11) EPS.

Separately, Ventum Cap Mkts raised Jushi to a “hold” rating in a research note on Thursday, August 8th.

Jushi Stock Up 16.6 %

JUSHF stock opened at $0.41 on Wednesday. The company has a 50-day simple moving average of $0.50 and a 200 day simple moving average of $0.57. Jushi has a fifty-two week low of $0.22 and a fifty-two week high of $1.09.

Jushi (OTCMKTS:JUSHF) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.08) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.04). Jushi had a negative net margin of 20.93% and a negative return on equity of 5,529.11%. The business had revenue of $61.61 million for the quarter, compared to the consensus estimate of $65.53 million.

Jushi Company Profile

Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.